DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+38.59%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$144M
AUM Growth
+$144M
Cap. Flow
-$16.4M
Cap. Flow %
-11.4%
Top 10 Hldgs %
45.16%
Holding
105
New
10
Increased
14
Reduced
21
Closed
30

Top Buys

1
TNDM icon
Tandem Diabetes Care
TNDM
$3.15M
2
PTGX icon
Protagonist Therapeutics
PTGX
$2.62M
3
ARDX icon
Ardelyx
ARDX
$2.45M
4
XENE icon
Xenon Pharmaceuticals
XENE
$2.43M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
$2.25M

Top Sells

1
RIGL icon
Rigel Pharmaceuticals
RIGL
$5.53M
2
ABBV icon
AbbVie
ABBV
$4.73M
3
NVAX icon
Novavax
NVAX
$4M
4
DERM
Dermira, Inc.
DERM
$3.21M
5
NXTM
NxStage Medical Inc.
NXTM
$2.95M

Sector Composition

1 Healthcare 68.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VTAE
1
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$15M 10.43% 715,988 +55,800 +8% +$1.17M
CYNA
2
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$9.26M 6.45% 230,201 +7,842 +4% +$315K
ATRC icon
3
AtriCure
ATRC
$1.84B
$8.37M 5.83% 528,946 +15,000 +3% +$237K
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
$5.96M 4.15% 238,509 -118,000 -33% -$2.95M
TNDM icon
5
Tandem Diabetes Care
TNDM
$845M
$5.55M 3.86% 724,286 +411,530 +132% +$3.15M
ALDR
6
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$5.42M 3.77% 165,313 – –
GLPG icon
7
Galapagos
GLPG
$2.07B
$4.27M 2.98% 66,068 +2,500 +4% +$162K
XENE icon
8
Xenon Pharmaceuticals
XENE
$2.98B
$4.16M 2.9% 514,091 +300,000 +140% +$2.43M
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$3.47M 2.41% 91,869 -69,000 -43% -$2.6M
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
$3.41M 2.37% 130,222 +28,256 +28% +$740K
DERM
11
DELISTED
Dermira, Inc.
DERM
$3.34M 2.33% 98,800 -94,842 -49% -$3.21M
NBIX icon
12
Neurocrine Biosciences
NBIX
$13.8B
$3.24M 2.26% 64,008 -11,495 -15% -$582K
PODD icon
13
Insulet
PODD
$23.9B
$3.01M 2.1% 73,484 -18,680 -20% -$765K
TSRO
14
DELISTED
TESARO, Inc.
TSRO
$2.96M 2.06% 29,500 -500 -2% -$50.1K
ARDX icon
15
Ardelyx
ARDX
$1.53B
$2.84M 1.97% 219,095 +189,095 +630% +$2.45M
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$2.78M 1.93% 90,142 +70,142 +351% +$2.16M
PTGX icon
17
Protagonist Therapeutics
PTGX
$3.67B
$2.62M 1.82% +123,804 New +$2.62M
FOMX
18
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.58M 1.79% 278,067 +85,500 +44% +$792K
AGTC
19
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.35M 1.64% 240,298 +73,106 +44% +$715K
RCKT icon
20
Rocket Pharmaceuticals
RCKT
$354M
$2.25M 1.57% +237,235 New +$2.25M
SYRE icon
21
Spyre Therapeutics
SYRE
$996M
$2.25M 1.56% 350,392 – –
TVRD
22
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
$2.23M 1.55% 267,046 – –
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.15M 1.5% +46,600 New +$2.15M
RDUS
24
DELISTED
Radius Health, Inc.
RDUS
$1.99M 1.39% 36,854 -746 -2% -$40.3K
IMMU
25
DELISTED
Immunomedics Inc
IMMU
$1.84M 1.28% 566,796 -248,204 -30% -$807K
1
2 3 4